Reed Elsevier PLC
18 June 2003
Issued on behalf of Reed Elsevier PLC and Reed Elsevier NV
Reed Elsevier Announces Board Change
Reed Elsevier Group plc today announced that Mr Derk Haank is to resign from
Reed Elsevier with immediate effect. Mr Haank has been a director of Reed
Elsevier and chief executive of the group's science and medical division.
Mr Haank plans, in early 2004, to take up the post of chief executive of
Springer, the science and business publishing business acquired (subject to
regulatory approval) by Cinven and Candover, the European buyout specialists.
Mr Crispin Davis, Chief Executive Officer of Reed Elsevier, commented: 'We are
of course sorry to see Derk Haank leave the company. He has made a major
contribution to the development of the science and medical business over the
last five years, most recently in the successful integration of the Harcourt
acquisition.' He added: 'The business is in very good shape, has a strong
management team, and should see another year of significant outperformance of
its markets. We will be taking steps to appoint a new chief executive of the
division.'
-ends-
For further information please contact:
Catherine May, Reed Elsevier, tel +44 (0) 20 7222 8420
Notes to editors
Reed Elsevier Group plc
Reed Elsevier Group plc is a world leading publisher and information provider.
It is owned equally by its two parent companies, Reed Elsevier PLC and Reed
Elsevier NV. The parent companies are listed on the London, Amsterdam and New
York Stock Exchanges, under the following ticker symbols: London: REL; Amsterdam
: REN; New York: RUK and ENL. In 2002, Reed Elsevier made adjusted profit
before taxation of £927 million (€1,474 million) on turnover of £5,020 million
(€7,982 million). The group employs 36,000 people, including approximately
22,000 in North America. Operating in the scientific, legal, educational and
business-to-business sectors, Reed Elsevier provides high value and flexible
information solutions to professional end users, with increasing emphasis on
internet delivery.
For further information, please visit the company website www.reedelsevier.com.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.